箭頭製藥公司
MX ˙ BMV ˙ US04280A1007
SecurityMX:ARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionFORA Capital, LLC
Latest Disclosed Ownership23,625 shares
Latest Disclosed Value $ 1,482,232
FORA Capital, LLC reports 114.77% increase in ownership of ARWR / Arrowhead Pharmaceuticals, Inc.

On May 14, 2026 - FORA Capital, LLC filed a 13F-HR form disclosing ownership of 23,625 shares of Arrowhead Pharmaceuticals, Inc. (MX:ARWR) valued at $1,482,232 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 11,000 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of 114.77% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 23,625 12,625 114.77 1,482 103.01 0.1086
2026-02-13 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 11,000 11,000 730 0.0883
2021-11-15 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -6,446 -100.00 0 -100.00
2021-08-16 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 6,446 6,446 534 0.0993
2021-05-17 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -2,108 -100.00 0 -100.00
2021-02-12 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 2,108 -3,229 -60.50 162 -29.57 0.0247
2020-11-13 2020-09-30 13F ARROWHEAD PHARMACEUTICALS, INC. CMN COM 04280A100 5,337 -7,967 -59.88 230 -60.00 0.1508
2020-08-14 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN CMN COM 04280A100 13,304 -1,184 -8.17 575 37.89 0.1968
2020-05-15 2020-03-31 13F ARROWHEAD PHARMACEUTICALS COM 04280A100 14,488 938 6.92 417 -51.46 0.0900
2020-02-14 2019-12-31 13F ARROWHEAD PHARMACEUTICALS INC CMN COM 04280A100 13,550 13,550 859 0.0866
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.